172 related articles for article (PubMed ID: 19703300)
1. Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.
Pinkawa M; Fischedick K; Gagel B; Piroth MD; Asadpour B; Klotz J; Borchers H; Jakse G; Eble MJ
BMC Cancer; 2009 Aug; 9():296. PubMed ID: 19703300
[TBL] [Abstract][Full Text] [Related]
2. Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose.
Pinkawa M; Gharib A; Schlenter M; Timm L; Eble MJ
Qual Life Res; 2021 Feb; 30(2):437-443. PubMed ID: 33034812
[TBL] [Abstract][Full Text] [Related]
3. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
Karakiewicz PI; Bhojani N; Neugut A; Shariat SF; Jeldres C; Graefen M; Perrotte P; Peloquin F; Kattan MW
J Sex Med; 2008 Apr; 5(4):919-927. PubMed ID: 18371045
[TBL] [Abstract][Full Text] [Related]
4. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
7. A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.
Caumont F; Conti G; Hurwitz LM; Kuo C; Levie KE; Badiozamani K; Frankel JK; Flores JP; Brand TC; Chaurasia A; Rosner IL; Stroup SP; Musser JE; Cullen J; Porter CR
Urol Oncol; 2020 Oct; 38(10):794.e1-794.e9. PubMed ID: 32139288
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Nussen S; Eble MJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):83-9. PubMed ID: 17855010
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer.
Yamamoto S; Fujii Y; Masuda H; Urakami S; Saito K; Kozuka T; Oguchi M; Fukui I; Yonese J
Qual Life Res; 2014 Jun; 23(5):1641-50. PubMed ID: 24338068
[TBL] [Abstract][Full Text] [Related]
11. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
Dragićević S
Urol Int; 2010; 85(2):173-9. PubMed ID: 20606405
[TBL] [Abstract][Full Text] [Related]
14. Quality-of-life outcomes in men treated for localized prostate cancer.
Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Leach GE; Brook RH
JAMA; 1995 Jan; 273(2):129-35. PubMed ID: 7799493
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors.
Polter EJ; Wheldon CW; Rosser BRS; Kohli N; Capistrant BD; Kapoor A; Konety B; Mitteldorf D; Ross M; Talley KMC; Terveen L; West W; Wright MM
Psychooncology; 2019 Dec; 28(12):2351-2357. PubMed ID: 31518042
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.
Hoffman RM; Gilliland FD; Penson DF; Stone SN; Hunt WC; Potosky AL
Cancer; 2004 Nov; 101(9):2011-9. PubMed ID: 15452835
[TBL] [Abstract][Full Text] [Related]
18. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
[TBL] [Abstract][Full Text] [Related]
19. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
20. The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
Bhojani N; Perrotte P; Jeldres C; Suardi N; Hutterer G; Shariat SF; Karakiewicz PI
J Sex Med; 2008 Mar; 5(3):668-76. PubMed ID: 18221289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
